ComicBooks.com Register / Loginit's free!
Kill Shakespeare #3 cover

Kill Shakespeare #3

Sep 2013 · IDW · 19.99 USD
📊 ~3,861 copies sold its debut month
☆ Be the first to review + Add to your collection — Join free
About this Collection

This third volume of the Kill Shakespeare series continues the dark fantasy reimagining of the Bard's characters, pitting them in a struggle for control over a magical artifact known as the Shadow King's dagger. The Tide of Blood collects issues #13–18 of the ongoing comic, written by Conor McCreery and Anthony Del Col, with art by Andy Belanger.

collection editor Alonzo Simon · artist Andy Belanger · writer Anthony Del Col · letterer, designer Chris Mowry · editor in chief, chief creative officer Chris Ryall · writer Conor McCreery · president Greg Goldstein · collection editor Justin Eisinger · designer Robbie Robbins · colorist Shari Chankhamma · cover Simon Davis · publisher Ted Adams · editor Tom Waltz

Find on

Search eBay for Kill Shakespeare #3
No confirmed live listings for this exact issue right now — this opens an eBay search.

Where to buy

Find on Amazon 🛒 Buy on Amazon
Kill Shakespeare Volume 3: The Tide of Blood

Read it digitally

Amazon Kindle Buy the digital edition GlobalComix Indie & digital reader
Opens a search on each platform — digital availability varies by title.

Sell my copy

Have this issue — or a whole collection? Get a fair offer from us, skip the marketplace fees and the hassle.

We Buy Collections ▸
Fast, fair offers · we handle grading & shipping

Full credits

collection editor Alonzo Simon
letterer, designer Chris Mowry
editor in chief, chief creative officer Chris Ryall
president Greg Goldstein
collection editor Justin Eisinger
publisher Ted Adams
editor Tom Waltz

Reprints

↩ Reprints Kill Shakespeare: The Tide of Blood #1 (2013), Kill Shakespeare: The Tide of Blood #3 (2013), Kill Shakespeare: The Tide of Blood #4 (2013), Kill Shakespeare: The Tide of Blood #5 (2013), Kill Shakespeare: The Tide of Blood #2

Reviews

Reader reviews

No reader reviews yet.